Ontology highlight
ABSTRACT: Background
Patients with residual muscle-invasive urinary tract cancer after neoadjuvant chemotherapy (NAC) have a high risk of recurrence.Objective
To retrospectively evaluate whether additional adjuvant chemotherapy (AC) improves outcomes compared with surveillance in patients with significant residual disease despite NAC.Design, setting, and participants
We identified 474 patients who received NAC from the Retrospective International Study of Cancers of the Urothelium database, of whom 129 had adverse residual disease (≥ypT3 and/or ypN+).Outcome measurements and statistical analysis
Time to relapse (TTR) was the primary endpoint assessed starting from 2mo after surgery to minimize immortal time bias. Secondary endpoints included overall surviva
SUBMITTER: Martinez Chanza N
PROVIDER: S-EPMC8449851 | biostudies-literature | 2020 Oct
REPOSITORIES: biostudies-literature